Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | EW | JNJ |
|---|
| Close | 89.28 | 267.28 |
| Market Cap | $51.5B | $644B |
| 1M | −1.68% | +1.87% |
| P/E (TTM) | 51.2 | 30.6 |
| Forward P/E | 29.8 | 20.7 |
| P/E 5-Yr Percentile | 98 | 90 |
| P/S | 7.9 | 6.6 |
| P/B | 4.9 | 7.6 |
| Dividend Yield | — | 3.12% |
| Latest Quarter Revenue | $1.7B | $25.3B |
| Revenue YoY | +13.6% | +6.6% |
| Gross Margin | 77.5% | 68.2% |
| Latest Quarter EPS | 0.42 | 2.27 |
| Avg Post-Earnings Move | ±3.9% | ±0.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.34% | 1.25% |
| 90-Day Net Insider Buying | −$4.6M | −$67.8M |
EW · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
